Inverted ILM-flap Techniques Variants for Macular Hole Surgery: Outcomes Comparison
Macular Holes
About this trial
This is an interventional other trial for Macular Holes
Eligibility Criteria
Inclusion Criteria:
- patients with idiopatic macular holes
Exclusion Criteria:
- Patients with MH duration greater than 6 months
- myopia exceeding 6 diopters
- history of trauma
- previous ocular surgery except uncomplicated cataract extraction with in-the-bag IOL implantation
- any ocular illness including glaucoma, uveitis, optic nerve pathology
Sites / Locations
- University of MoliseRecruiting
Arms of the Study
Arm 1
Arm 2
Other
Other
Cover Group (CG)
Fill Group (FG)
All patients will undergo a 25G standard 3-port PPV with posterior vitreous detachment induction (if not already present), ILM staining with 0,25 g/l of brilliant blue-G and creation of a 360°ILM flap around the MH rim. Phakic patients will undergo combined phacoemulsification with IOL implant in-the-bag. In the Cover Group the ILM flap will be folded as a single layer to bridge tissue dehiscence during air-fluid exchange. All eyes will recive a mixture of 20% sulfur hexafluoride tamponade and will be instructed to position face down for 4 hours a day during the first 3 days post-operative
All patients will undergo a 25G standard 3-port PPV with posterior vitreous detachment induction (if not already present), ILM staining with 0,25 g/l of brilliant blue-G and creation of a 360°ILM flap around the MH rim. Phakic patients will undergo combined phacoemulsification with IOL implant in-the-bag. In the Fill Group, multiple layers of ILM will be deliberately folded within the loss of tissue before air-fluid exchange. All eyes will receive a mixture of 20% sulfur hexafluoride tamponade and will be instructed to position face down for 4 hours a day during the first 3 days post-operative